| |
Analysis of the long-term effects of drug-eluting stents on coronary arterial wall morphology as assessed by virtual histology intravascular ultrasound
Am Heart J, 2010. 159(2): p. 271-7.
T. Kubo, et al., |
| |
Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II)
Heart, 2009. 95(13): p. 1061-6.
N. Kukreja, et al., |
| |
Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program
Circulation, 2009. 119(7): p. 952-61.
J. Ryan, et al., |
| |
Volumetric intravascular ultrasound analysis of Paclitaxel-eluting and bare metal stents in acute myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy
Circulation, 2009. 120(19): p. 1875-82.
A. Maehara, et al., |
| |
Comparison of bare metal stenting and percutaneous pulmonary valve implantation for treatment of right ventricular outflow tract obstruction: use of an x-ray/magnetic resonance hybrid laboratory for acute physiological assessment
Circulation, 2009. 119(23): p. 2995-3001.
P. Lurz, et al., |
| |
Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies
Circulation, 2009. 119(25): p. 3198-206.
A. J. Kirtane, et al., |
| |
Long-term safety and effectiveness of unprotected left main coronary stenting with drug-eluting stents compared with bare-metal stents
Circulation, 2009. 120(5): p. 400-7.
Y. H. Kim, et al., |
| |
Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial
Circulation, 2009. 120(11): p. 964-72.
E. Di Lorenzo, et al., |
| |
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial
Circulation, 2009. 119(5): p. 687-98.
J. Aoki, et al., |
| |
Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima
Circ Cardiovasc Interv, 2009. 2(3): p. 205-12.
S. Yokoyama, et al., |
| |
A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial)
Circ Cardiovasc Interv, 2009. 2(2): p. 113-23.
R. J. Russo, et al., |
| |
Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes
Circ Cardiovasc Interv, 2009. 2(1): p. 35-42.
R. J. Applegate, et al., |
| |
Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis
Catheter Cardiovasc Interv, 2009.
I. M. Singh, et al., |
| |
Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy
Catheter Cardiovasc Interv, 2009. 74(4): p. 543-9.
T. Nfor, et al., |
| |
Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial
Catheter Cardiovasc Interv, 2009. 73(6): p. 771-9.
V. Dzavik, et al., |
| |
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry
Catheter Cardiovasc Interv, 2009. 73(3): p. 310-6.
D. Capodanno, et al., |
| |
Comparison of neointimal hyperplasia with drug-eluting stents versus bare metal stents in patients undergoing intracoronary bone-marrow mononuclear cell transplantation following acute myocardial infarction
Am J Cardiol, 2009. 103(12): p. 1651-6.
A. Villa, et al., |
| |
Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents
Am J Cardiol, 2009. 104(9): p. 1229-34.
J. P. van Kuijk, et al., |
| |
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes
Am J Cardiol, 2009. 103(2): p. 187-93.
C. Tamburino, et al., |
| |
Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents
Am J Cardiol, 2009. 103(4): p. 491-5.
D. H. Steinberg, et al., |
| |
Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection
Am J Cardiol, 2009. 104(2): p. 216-22.
X. Ren, et al., |
| |
Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction
Am J Cardiol, 2009. 103(12): p. 1672-4.
B. Pierre-Louis, et al., |
| |
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)
Am J Cardiol, 2009. 103(2): p. 181-6.
M. R. Patel, et al., |
| |
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry)
Am J Cardiol, 2009. 104(10): p. 1362-9.
C. A. Nienaber, et al., |
| |
Frequency of coronary artery bypass grafting following implantation of a paclitaxel-eluting or a bare-metal stent into a single coronary artery
Am J Cardiol, 2009. 103(1): p. 11-6.
J. L. Martin, et al., |
| |
An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents
Am J Cardiol, 2009. 103(4): p. 501-6.
J. Liu, et al., |
| |
Three-year survival following multivessel percutaneous coronary intervention with bare-metal or drug-eluting stents in unselected patients
Am J Cardiol, 2009. 103(2): p. 203-11.
N. Kukreja, et al., |
| |
Impact of different re-stenting strategies on expansion of a drug-eluting stent implanted to treat bare-metal stent restenosis
Am J Cardiol, 2009. 104(4): p. 531-7.
L. Kalinczuk, et al., |
| |
Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings
Am J Cardiol, 2009. 103(11): p. 1537-45.
K. J. Harjai, et al., |
| |
Comparison of long-term efficacy of the paclitaxel-eluting stent versus the bare-metal stent for treatment of unprotected left main coronary artery disease
Am J Cardiol, 2009. 103(2): p. 194-8.
Y. Han, et al., |
| |
Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents
Am J Cardiol, 2009. 104(12): p. 1660-7.
A. Chieffo, et al., |
| |
Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries
Am J Cardiol, 2009. 103(4): p. 496-500.
L. Bonello, et al., |
| |
Drug-eluting versus bare-metal stents for treating saphenous vein grafts
Am Heart J, 2009. 158(4): p. 637-43.
M. H. Shishehbor, et al., |
| |
Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study)
Am Heart J, 2009. 157(1): p. 149-55.
B. M. Rahel, et al., |
| |
Stent thrombosis up to 3 years after stenting for ST-segment elevation myocardial infarction versus for stable angina--comparison of the effects of drug-eluting versus bare-metal stents
Am Heart J, 2009. 158(2): p. 271-6.
G. Leibundgut, et al., |
| |
Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drug-eluting stents and bare-metal stents
Am Heart J, 2009. 158(4): p. 592-598 e1.
D. T. Ko, et al., |
| |
Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial
Am Heart J, 2009. 158(4): p. e43-50.
E. Di Lorenzo, et al., |
| |
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
N Engl J Med, 2009. 360(19): p. 1946-59.
G. W. Stone, et al., |
| |
Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden
N Engl J Med, 2009. 360(19): p. 1933-45.
S. K. James, et al., |
| |
Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia
JACC Cardiovasc Interv, 2009. 2(4): p. 329-36.
M. H. Shishehbor, et al., |
| |
Baseline fractional flow reserve and stent diameter predict optimal post-stent fractional flow reserve and major adverse cardiac events after bare-metal stent deployment
JACC Cardiovasc Interv, 2009. 2(4): p. 357-63.
H. Samady, et al., |
| |
Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries
JACC Cardiovasc Interv, 2009. 2(7): p. 603-10.
Y. Onuma, et al., |
| |
The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents
JACC Cardiovasc Interv, 2009. 2(6): p. 534-41.
N. Kukreja, et al., |
| |
Comparison of drug-eluting and bare-metal stents for stable coronary artery disease
JACC Cardiovasc Interv, 2009. 2(4): p. 321-8.
B. Horst, et al., |
| |
The PASEO (PaclitAxel or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty) Randomized Trial
JACC Cardiovasc Interv, 2009. 2(6): p. 515-23.
E. Di Lorenzo, et al., |
| |
Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting
JACC Cardiovasc Interv, 2009. 2(6): p. 498-503.
R. Chacko, et al., |
| |
3-year comparison of drug-eluting versus bare-metal stents
JACC Cardiovasc Interv, 2009. 2(3): p. 231-9.
R. J. Applegate, et al., |
| |
Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications
J Am Coll Cardiol, 2009. 53(19): p. 1773-82.
D. T. Ko, et al., |
| |
2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)
J Am Coll Cardiol, 2009. 53(8): p. 658-64.
A. Kaltoft, et al., |
| |
Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria
J Am Coll Cardiol, 2009. 53(16): p. 1389-98.
J. Carlsson, et al., |
| |
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents
J Am Coll Cardiol, 2009. 54(10): p. 894-902.
A. Caixeta, et al., |
| |
A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial
J Am Coll Cardiol, 2009. 53(11): p. 919-28.
E. S. Brilakis, et al., |
| |
| |
| |
 |